Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.

Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study. J Clin Oncol. 2010 Feb 01; 28(4):596-604.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Biomarkers, Tumor
CCAAT-Enhancer-Binding Proteins
Female
fms-Like Tyrosine Kinase 3
Gene Expression Profiling
Gene Expression Regulation, Leukemic
Humans
Karyotyping
Leukemia, Myeloid, Acute
Male
MicroRNAs
Middle Aged
Mutation
Neoplasm Staging
Nuclear Proteins
Oligonucleotide Array Sequence Analysis
Prognosis
Remission Induction
Survival Rate
Treatment Outcome
WT1 Proteins

authors with profiles

Richard A. Larson